These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 25712794)

  • 21. Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia.
    Hammami S; Saidani M; Ferjeni S; Aissa I; Slim A; Boutiba-Ben Boubaker I
    Microb Drug Resist; 2013 Jun; 19(3):231-6. PubMed ID: 23363379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Characteristics of Sequence Type 131
    Park JY; Yun KW; Choi EH; Lee HJ
    Microb Drug Resist; 2018 Dec; 24(10):1552-1558. PubMed ID: 29957128
    [No Abstract]   [Full Text] [Related]  

  • 23. High prevalence of B2-ST131 clonal group among extended-spectrum β-lactamase-producing Escherichia coli isolated from bloodstream infections in Quito, Ecuador.
    Zurita J; Solís MB; Ortega-Paredes D; Barba P; Paz Y Miño A; Sevillano G
    J Glob Antimicrob Resist; 2019 Dec; 19():216-221. PubMed ID: 31077859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections.
    Smet A; Martel A; Persoons D; Dewulf J; Heyndrickx M; Claeys G; Lontie M; Van Meensel B; Herman L; Haesebrouck F; Butaye P
    Microb Drug Resist; 2010 Jun; 16(2):129-34. PubMed ID: 20370505
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole genome analysis of cephalosporin-resistant Escherichia coli from bloodstream infections in Australia, New Zealand and Singapore: high prevalence of CMY-2 producers and ST131 carrying blaCTX-M-15 and blaCTX-M-27.
    Harris PNA; Ben Zakour NL; Roberts LW; Wailan AM; Zowawi HM; Tambyah PA; Lye DC; Jureen R; Lee TH; Yin M; Izharuddin E; Looke D; Runnegar N; Rogers B; Bhally H; Crowe A; Schembri MA; Beatson SA; Paterson DL;
    J Antimicrob Chemother; 2018 Mar; 73(3):634-642. PubMed ID: 29253152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dissemination of ST131 and ST393 community-onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea.
    Lee MY; Choi HJ; Choi JY; Song M; Song Y; Kim SW; Chang HH; Jung SI; Kim YS; Ki HK; Son JS; Kwon KT; Heo ST; Yeom JS; Shin SY; Chung DR; Peck KR; Song JH; Ko KS
    J Infect; 2010 Feb; 60(2):146-53. PubMed ID: 19932131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Turkey: a further country concerned by community-acquired Escherichia coli clone O25-ST131 producing CTX-M-15.
    Yumuk Z; Afacan G; Nicolas-Chanoine MH; Sotto A; Lavigne JP
    J Antimicrob Chemother; 2008 Aug; 62(2):284-8. PubMed ID: 18453527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence and quinolone resistance of fecal carriage of extended-spectrum β-lactamase-producing Escherichia coli in 6 communities and 2 physical examination center populations in Shanghai, China.
    Ni Q; Tian Y; Zhang L; Jiang C; Dong D; Li Z; Mao E; Peng Y
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):428-433. PubMed ID: 27681363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of extended-spectrum β-lactamase-producing Escherichia coli in Sweden 2007-2011.
    Brolund A; Edquist PJ; Mäkitalo B; Olsson-Liljequist B; Söderblom T; Wisell KT; Giske CG
    Clin Microbiol Infect; 2014 Jun; 20(6):O344-52. PubMed ID: 24118431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella spp. isolates in Mongolia.
    Kao CY; Udval U; Huang YT; Wu HM; Huang AH; Bolormaa E; Yan JJ; Urangoo Z; Batbaatar G; Khosbayar T; Wu JJ
    J Microbiol Immunol Infect; 2016 Oct; 49(5):692-700. PubMed ID: 26194952
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genomic landscape of extended-spectrum β-lactamase resistance in Escherichia coli from an urban African setting.
    Musicha P; Feasey NA; Cain AK; Kallonen T; Chaguza C; Peno C; Khonga M; Thompson S; Gray KJ; Mather AE; Heyderman RS; Everett DB; Thomson NR; Msefula CL
    J Antimicrob Chemother; 2017 Jun; 72(6):1602-1609. PubMed ID: 28333330
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical epidemiology and molecular analysis of extended-spectrum-β-lactamase-producing Escherichia coli in Nepal: characteristics of sequence types 131 and 648.
    Sherchan JB; Hayakawa K; Miyoshi-Akiyama T; Ohmagari N; Kirikae T; Nagamatsu M; Tojo M; Ohara H; Sherchand JB; Tandukar S
    Antimicrob Agents Chemother; 2015; 59(6):3424-32. PubMed ID: 25824221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular epidemiology of fluoroquinolone-resistant ST131 Escherichia coli producing CTX-M extended-spectrum beta-lactamases in nursing homes in Belfast, UK.
    Dhanji H; Doumith M; Rooney PJ; O'Leary MC; Loughrey AC; Hope R; Woodford N; Livermore DM
    J Antimicrob Chemother; 2011 Feb; 66(2):297-303. PubMed ID: 21131323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance and virulence of uropathogenic Escherichia coli from Shanghai, China.
    Wang Y; Zhao S; Han L; Guo X; Chen M; Ni Y; Zhang Y; Cui Z; He P
    J Antibiot (Tokyo); 2014 Dec; 67(12):799-805. PubMed ID: 24984795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial Resistance and Molecular Epidemiology of
    Xiao S; Tang C; Zeng Q; Xue Y; Chen Q; Chen E; Han L
    Front Med (Lausanne); 2021; 8():803837. PubMed ID: 35083253
    [No Abstract]   [Full Text] [Related]  

  • 36. Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2.
    Oteo J; Diestra K; Juan C; Bautista V; Novais A; Pérez-Vázquez M; Moyá B; Miró E; Coque TM; Oliver A; Cantón R; Navarro F; Campos J;
    Int J Antimicrob Agents; 2009 Aug; 34(2):173-6. PubMed ID: 19464856
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic diversity, antimicrobial resistance and extended-spectrum β-lactamase type of Escherichia coli isolates from chicken, dog, pig and yak in Gansu and Qinghai Provinces, China.
    Wang Y; Zhou J; Li X; Ma L; Cao X; Hu W; Zhao L; Jing W; Lan X; Li Y; Gong X; Chen Q; Stipkvits L; Szathmary S; Tarasiuk K; Pejsak Z; Liu Y
    J Glob Antimicrob Resist; 2020 Sep; 22():726-732. PubMed ID: 32659505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular characteristics of extended-spectrum beta-lactamase-producing Escherichia coli from the Chicago area: high prevalence of ST131 producing CTX-M-15 in community hospitals.
    Peirano G; Costello M; Pitout JD
    Int J Antimicrob Agents; 2010 Jul; 36(1):19-23. PubMed ID: 20359869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CTX-M-15-producing urinary Escherichia coli O25b-ST131-phylogroup B2 has acquired resistance to fosfomycin.
    Oteo J; Orden B; Bautista V; Cuevas O; Arroyo M; Martínez-Ruiz R; Pérez-Vázquez M; Alcaraz M; García-Cobos S; Campos J
    J Antimicrob Chemother; 2009 Oct; 64(4):712-7. PubMed ID: 19671590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
    Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
    Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.